US pharma manufacturer Eli Lilly has increased its full-year revenue projection by $2 billion, buoyed by robust sales of its weight-loss drugs.Revenue surged by 26 percent to $8.76 billion in the first quarter of 2024, propelled by key products including Mounjaro, Zepbound, Verzenio, and Jardiance, as stated during an investor briefing on April 30.Mounjaro (a type 2 diabetes drug).
Open FlipThe recent sharp correction in Gold prices, where the yellow metal has corrected by nearly Rs 3000 per 10 gram or 4% from the lifetime high is its biggest fall in nearly two years. Can we expect the trends to reverse or a top has been made? This is what multiple experts tell ETMakets as they spell out their trading strategy.Notwithstanding the fall seen in yellow metal over the last two weeks.
Open FlipMid-cap information technology (IT) company Birlasoft said a “perfect storm” of uncertainty has made it difficult for both the industry as a whole and the company itself to reasonably forecast growth outlook.The combined effect of economic uncertainty, varying GDP growth rates across nations, and geopolitical conflicts have created an unpredictable demand environment.
Open Flip